September 2011 Issue
The best companies build SCRM into their culture, allowing it to inform all business decisions.
Makers of drugs for lethal injection face pressure to spurn U.S. prisons.
Rapid microbiological methods continue to be developed in order to support or supplant compendial methods.
Is an overly rigid FDA causing today's chronic drug shortages? Or is it an industry that still struggles to meet the most basic quality standards?
A standardized, recipe-based approach adds value and turns data into actionable knowledge.
At look at how HACCP and FMEA can make a difference in the pharma micro lab.
When GMP's fail offshore, insufficient knowledge transfer is usually at the root of the problem.
Enforcing existing laws is a start.
Twitter is a social, ever-changing platform. But its manners remain the same.
Pharma Tech Industries Preston Wright talks about the need to move to a consistent quality presence that is both efficient and effective.
Biosimilars and productivity improvements are driving the market.
Science-based is well and good, but FDAs guidance may create confusion.